サマリー

カナダのプロバイオティクスサプリメントの世界市場 2022-2026 年
Technavioはカナダのプロバイオティクスサプリメント市場を監視しており、2022-2026年の間に5976万ドルの成長が見込まれ、予測期間中にCAGR5.9％で加速しています。カナダのプロバイオティクスサプリメント市場に関する当レポートでは、全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析などを提供しています。
同国の現在の市場シナリオ、最新動向と促進要因、市場全体の環境について最新の分析を提供しています。生活習慣病に対する意識の高まり、プロバイオティクスサプリメントの利点に対する認知度の上昇、消化器系疾患の有病率の上昇などが市場を牽引しています。
カナダのプロバイオティクスサプリメント市場の分析には、タイプ別セグメントと地理的展望が含まれます。
Technavioのカナダのプロバイオティクスサプリメント市場は、以下のようにセグメント化されています。
タイプ別
- 細菌
- 酵母
本調査では、集中的な研究開発が今後数年間のカナダのプロバイオティクスサプリメント市場の成長を促進する主要な理由の1つであることを確認します。また、体重管理製品の需要の増加とオンライン購入の可用性は、市場のかなりの需要につながるでしょう。
Technavio社は、複数の情報源からのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。カナダのプロバイオティクスサプリメント市場に関する当レポートは、以下の分野を対象としています。
- カナダのプロバイオティクスサプリメント市場規模
- カナダのプロバイオティクスサプリメント市場予測
- カナダのプロバイオティクスサプリメント市場の産業分析
Technavioの強力なベンダー分析は、顧客が市場での地位を向上できるように設計されており、これに沿って本レポートでは、カナダのプロバイオティクスサプリメント市場の主要ベンダー数社について詳細な分析を提供しています。 その中には、American Biologics LLC、Biena Inc.、BioGaia AB、Biotix Care、Church and Dwight Co,CUSTOM PROBIOTICS Inc.、Deerland Probiotics and Enzymes Inc.、International Flavors and Fragrances Inc.、Kerry Group Plc、Kirkman Group、Koninklijke DSM NV、Lallemand Inc、Natural Factors Nutritional Products Ltd、NOVA Essentials Inc、Probi AB、Reckitt Benckiser Group PLC、Renew Life、およびThe Procter and Gamble Co.などのメーカーが含まれています。また、カナダのプロバイオティクスサプリメント市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後の成長機会をすべて戦略的に活用できるようにするためです。
本調査は、業界の主要参加者からのインプットを含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/probiotic-supplements-market-industry-in-canada-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Country Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Disease Type
o Exhibit 06: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 07: Parent market
o Exhibit 08: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 09: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 10: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 11: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 12: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 13: Chart on Canada: Year-over-year growth 2021-2026 (%)
o Exhibit 14: Data Table on Canada: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 15: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 16: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 17: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 18: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 19: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 20: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 21: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Type
o 5.1 Market segments
o Exhibit 22: Chart on Type - Market share 2021-2026 (%)
o Exhibit 23: Data Table on Type - Market share 2021-2026 (%)
o 5.2 Comparison by Type
o Exhibit 24: Chart on Comparison by Type
o Exhibit 25: Data Table on Comparison by Type
o 5.3 Bacteria - Market size and forecast 2021-2026
o Exhibit 26: Chart on Bacteria - Market size and forecast 2021-2026 ($ million)
o Exhibit 27: Data Table on Bacteria - Market size and forecast 2021-2026 ($ million)
o Exhibit 28: Chart on Bacteria - Year-over-year growth 2021-2026 (%)
o Exhibit 29: Data Table on Bacteria - Year-over-year growth 2021-2026 (%)
o 5.4 Yeast - Market size and forecast 2021-2026
o Exhibit 30: Chart on Yeast - Market size and forecast 2021-2026 ($ million)
o Exhibit 31: Data Table on Yeast - Market size and forecast 2021-2026 ($ million)
o Exhibit 32: Chart on Yeast - Year-over-year growth 2021-2026 (%)
o Exhibit 33: Data Table on Yeast - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Type
o Exhibit 34: Market opportunity by Type ($ million)
• 6 Market Segmentation by Disease Type
o 6.1 Market segments
o Exhibit 35: Chart on Disease Type - Market share 2021-2026 (%)
o Exhibit 36: Data Table on Disease Type - Market share 2021-2026 (%)
o 6.2 Comparison by Disease Type
o Exhibit 37: Chart on Comparison by Disease Type
o Exhibit 38: Data Table on Comparison by Disease Type
o 6.3 Gastrointestinal diseases - Market size and forecast 2021-2026
o Exhibit 39: Chart on Gastrointestinal diseases - Market size and forecast 2021-2026 ($ million)
o Exhibit 40: Data Table on Gastrointestinal diseases - Market size and forecast 2021-2026 ($ million)
o Exhibit 41: Chart on Gastrointestinal diseases - Year-over-year growth 2021-2026 (%)
o Exhibit 42: Data Table on Gastrointestinal diseases - Year-over-year growth 2021-2026 (%)
o 6.4 Infectious diseases - Market size and forecast 2021-2026
o Exhibit 43: Chart on Infectious diseases - Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Data Table on Infectious diseases - Market size and forecast 2021-2026 ($ million)
o Exhibit 45: Chart on Infectious diseases - Year-over-year growth 2021-2026 (%)
o Exhibit 46: Data Table on Infectious diseases - Year-over-year growth 2021-2026 (%)
o 6.5 Others - Market size and forecast 2021-2026
o Exhibit 47: Chart on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Data Table on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 49: Chart on Others - Year-over-year growth 2021-2026 (%)
o Exhibit 50: Data Table on Others - Year-over-year growth 2021-2026 (%)
o 6.6 Market opportunity by Disease Type
o Exhibit 51: Market opportunity by Disease Type ($ million)
• 7 Customer Landscape
o 7.1 Customer landscape overview
o Exhibit 52: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 53: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 54: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 55: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 56: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 57: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 58: Matrix on vendor position and classification
o 10.3 American Biologics LLC
o Exhibit 59: American Biologics LLC - Overview
o Exhibit 60: American Biologics LLC - Product / Service
o Exhibit 61: American Biologics LLC - Key offerings
o 10.4 BioGaia AB
o Exhibit 62: BioGaia AB - Overview
o Exhibit 63: BioGaia AB - Business segments
o Exhibit 64: BioGaia AB - Key news
o Exhibit 65: BioGaia AB - Key offerings
o Exhibit 66: BioGaia AB - Segment focus
o 10.5 Church and Dwight Co. Inc.
o Exhibit 67: Church and Dwight Co. Inc. - Overview
o Exhibit 68: Church and Dwight Co. Inc. - Business segments
o Exhibit 69: Church and Dwight Co. Inc. - Key news
o Exhibit 70: Church and Dwight Co. Inc. - Key offerings
o Exhibit 71: Church and Dwight Co. Inc. - Segment focus
o 10.6 Kerry Group Plc
o Exhibit 72: Kerry Group Plc - Overview
o Exhibit 73: Kerry Group Plc - Business segments
o Exhibit 74: Kerry Group Plc - Key news
o Exhibit 75: Kerry Group Plc - Key offerings
o Exhibit 76: Kerry Group Plc - Segment focus
o 10.7 Kirkman Group
o Exhibit 77: Kirkman Group - Overview
o Exhibit 78: Kirkman Group - Product / Service
o Exhibit 79: Kirkman Group - Key offerings
o 10.8 Koninklijke DSM NV
o Exhibit 80: Koninklijke DSM NV - Overview
o Exhibit 81: Koninklijke DSM NV - Business segments
o Exhibit 82: Koninklijke DSM NV - Key news
o Exhibit 83: Koninklijke DSM NV - Key offerings
o Exhibit 84: Koninklijke DSM NV - Segment focus
o 10.9 Lallemand Inc.
o Exhibit 85: Lallemand Inc. - Overview
o Exhibit 86: Lallemand Inc. - Product / Service
o Exhibit 87: Lallemand Inc. - Key offerings
o 10.10 Natural Factors Nutritional Products Ltd.
o Exhibit 88: Natural Factors Nutritional Products Ltd. - Overview
o Exhibit 89: Natural Factors Nutritional Products Ltd. - Product / Service
o Exhibit 90: Natural Factors Nutritional Products Ltd. - Key offerings
o 10.11 NOVA Essentials Inc.
o Exhibit 91: NOVA Essentials Inc. - Overview
o Exhibit 92: NOVA Essentials Inc. - Product / Service
o Exhibit 93: NOVA Essentials Inc. - Key offerings
o 10.12 Probi AB
o Exhibit 94: Probi AB - Overview
o Exhibit 95: Probi AB - Business segments
o Exhibit 96: Probi AB - Key offerings
o Exhibit 97: Probi AB - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 98: Inclusions checklist
o Exhibit 99: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 100: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 101: Research methodology
o Exhibit 102: Validation techniques employed for market sizing
o Exhibit 103: Information sources
o 11.5 List of abbreviations
o Exhibit 104: List of abbreviations
o food allergy among consumers: There is an increase in the number of people suffering from food allergies globally. Food allergy is caused when the immune system reacts to the ingestion of certain foods. Ingredients of packaged foods and meats that can create allergic reactions in some people include (but are not limited to) milk, eggs, fish, crustacean shellfish (e.g., crab, lobster, and shrimp), tree nuts (e.g., almonds, walnuts, and pecan), peanuts, wheat, and soybeans. Even consumption of small amounts of food allergens can trigger signs and symptoms such as digestive problems, hives, and swollen airways. In some people, a food allergy can cause severe symptoms, or even a life-threatening reaction is, known as anaphylaxis. For example, in the US, nearly 3% of the adult population suffers from shellfish allergy.


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Country Market Characteristics
Exhibits4: Executive Summary - Chart on Market Segmentation by Type
Exhibits5: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibits6: Executive Summary - Chart on Vendor Market Positioning
Exhibits7: Parent market
Exhibits8: Market Characteristics
Exhibits9: Offerings of vendors included in the market definition
Exhibits10: Market segments
Exhibits11: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits12: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits13: Chart on Canada: Year-over-year growth 2021-2026 (%)
Exhibits14: Data Table on Canada: Year-over-year growth 2021-2026 (%)
Exhibits15: Five forces analysis - Comparison between 2021 and 2026
Exhibits16: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits17: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits18: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits19: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits20: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits21: Chart on Market condition - Five forces 2021 and 2026
Exhibits22: Chart on Type - Market share 2021-2026 (%)
Exhibits23: Data Table on Type - Market share 2021-2026 (%)
Exhibits24: Chart on Comparison by Type
Exhibits25: Data Table on Comparison by Type
Exhibits26: Chart on Bacteria - Market size and forecast 2021-2026 ($ million)
Exhibits27: Data Table on Bacteria - Market size and forecast 2021-2026 ($ million)
Exhibits28: Chart on Bacteria - Year-over-year growth 2021-2026 (%)
Exhibits29: Data Table on Bacteria - Year-over-year growth 2021-2026 (%)
Exhibits30: Chart on Yeast - Market size and forecast 2021-2026 ($ million)
Exhibits31: Data Table on Yeast - Market size and forecast 2021-2026 ($ million)
Exhibits32: Chart on Yeast - Year-over-year growth 2021-2026 (%)
Exhibits33: Data Table on Yeast - Year-over-year growth 2021-2026 (%)
Exhibits34: Market opportunity by Type ($ million)
Exhibits35: Chart on Disease Type - Market share 2021-2026 (%)
Exhibits36: Data Table on Disease Type - Market share 2021-2026 (%)
Exhibits37: Chart on Comparison by Disease Type
Exhibits38: Data Table on Comparison by Disease Type
Exhibits39: Chart on Gastrointestinal diseases - Market size and forecast 2021-2026 ($ million)
Exhibits40: Data Table on Gastrointestinal diseases - Market size and forecast 2021-2026 ($ million)
Exhibits41: Chart on Gastrointestinal diseases - Year-over-year growth 2021-2026 (%)
Exhibits42: Data Table on Gastrointestinal diseases - Year-over-year growth 2021-2026 (%)
Exhibits43: Chart on Infectious diseases - Market size and forecast 2021-2026 ($ million)
Exhibits44: Data Table on Infectious diseases - Market size and forecast 2021-2026 ($ million)
Exhibits45: Chart on Infectious diseases - Year-over-year growth 2021-2026 (%)
Exhibits46: Data Table on Infectious diseases - Year-over-year growth 2021-2026 (%)
Exhibits47: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits48: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits49: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits50: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits51: Market opportunity by Disease Type ($ million)
Exhibits52: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits53: Impact of drivers and challenges in 2021 and 2026
Exhibits54: Overview on Criticality of inputs and Factors of differentiation
Exhibits55: Overview on factors of disruption
Exhibits56: Impact of key risks on business
Exhibits57: Vendors covered
Exhibits58: Matrix on vendor position and classification
Exhibits59: American Biologics LLC - Overview
Exhibits60: American Biologics LLC - Product / Service
Exhibits61: American Biologics LLC - Key offerings
Exhibits62: BioGaia AB - Overview
Exhibits63: BioGaia AB - Business segments
Exhibits64: BioGaia AB - Key news
Exhibits65: BioGaia AB - Key offerings
Exhibits66: BioGaia AB - Segment focus
Exhibits67: Church and Dwight Co. Inc. - Overview
Exhibits68: Church and Dwight Co. Inc. - Business segments
Exhibits69: Church and Dwight Co. Inc. - Key news
Exhibits70: Church and Dwight Co. Inc. - Key offerings
Exhibits71: Church and Dwight Co. Inc. - Segment focus
Exhibits72: Kerry Group Plc - Overview
Exhibits73: Kerry Group Plc - Business segments
Exhibits74: Kerry Group Plc - Key news
Exhibits75: Kerry Group Plc - Key offerings
Exhibits76: Kerry Group Plc - Segment focus
Exhibits77: Kirkman Group - Overview
Exhibits78: Kirkman Group - Product / Service
Exhibits79: Kirkman Group - Key offerings
Exhibits80: Koninklijke DSM NV - Overview
Exhibits81: Koninklijke DSM NV - Business segments
Exhibits82: Koninklijke DSM NV - Key news
Exhibits83: Koninklijke DSM NV - Key offerings
Exhibits84: Koninklijke DSM NV - Segment focus
Exhibits85: Lallemand Inc. - Overview
Exhibits86: Lallemand Inc. - Product / Service
Exhibits87: Lallemand Inc. - Key offerings
Exhibits88: Natural Factors Nutritional Products Ltd. - Overview
Exhibits89: Natural Factors Nutritional Products Ltd. - Product / Service
Exhibits90: Natural Factors Nutritional Products Ltd. - Key offerings
Exhibits91: NOVA Essentials Inc. - Overview
Exhibits92: NOVA Essentials Inc. - Product / Service
Exhibits93: NOVA Essentials Inc. - Key offerings
Exhibits94: Probi AB - Overview
Exhibits95: Probi AB - Business segments
Exhibits96: Probi AB - Key offerings
Exhibits97: Probi AB - Segment focus
Exhibits98: Inclusions checklist
Exhibits99: Exclusions checklist
Exhibits100: Currency conversion rates for US$
Exhibits101: Research methodology
Exhibits102: Validation techniques employed for market sizing
Exhibits103: Information sources
Exhibits104: List of abbreviations